APO Research
Talk to an analyst

APO RESEARCH · REPORT

Home Insulin Delivery (Dosing) Devices

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Home Insulin Delivery (Dosing) Devices Industry Growth and Trends Forecast to 2032

4 July 2026125 pages

Choose your research edition.

Industry ResearchHome Insulin Delivery (Dosing) Devices Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Home Insulin Delivery (Dosing) Devices Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Home Insulin Delivery (Dosing) Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Home Insulin Delivery (Dosing) Devices Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Home Insulin Delivery (Dosing) Devices Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Home Insulin Delivery (Dosing) Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Home Insulin Delivery (Dosing) Devices include Medtronic, Ypsomed Holding, Wockhardt, West Pharma, Valeritas, Tandem Diabetes Care, SOOIL, Sanofi and Roche Holding AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Home Insulin Delivery (Dosing) Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Home Insulin Delivery (Dosing) Devices market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Home Insulin Delivery (Dosing) Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Home Insulin Delivery (Dosing) Devices.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Home Insulin Delivery (Dosing) Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Home Insulin Delivery (Dosing) Devices Market by Company

Medtronic

Ypsomed Holding

Wockhardt

West Pharma

Valeritas

Tandem Diabetes Care

SOOIL

Sanofi

Roche Holding AG

Owen Mumford

Novo Nordisk

MannKind

Julphar

Insulet Corporation

Eli Lilly and Company

Debiotech

Dance Biopharm

Copernicus

Biocon

Beta Bionics

BD

B. Braun

Home Insulin Delivery (Dosing) Devices Segment by Type

Insulin Pumps

Insulin Pens

Insulin Syringes

Others

Home Insulin Delivery (Dosing) Devices Segment by Application

Online Pharmacy

Retail Pharmacy

Hospitals Pharmacy

Home Insulin Delivery (Dosing) Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Insulin Delivery (Dosing) Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Home Insulin Delivery (Dosing) Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Insulin Delivery (Dosing) Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Home Insulin Delivery (Dosing) Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Home Insulin Delivery (Dosing) Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulin Pumps Table 2. Major Company of Insulin Pens Table 3. Major Company of Insulin Syringes Table 4. Major Company of Others Table 5. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 7. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Type (2021-2026) Table 8. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (US$ Million) Table 9. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Type (2021-2026) Table 10. Global Home Insulin Delivery (Dosing) Devices Price by Type (2021-2026) & (USD/unit) Table 11. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (k units) Table 12. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Type (2027-2032) Table 13. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (US$ Million) Table 14. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Type (2027-2032) Table 15. Global Home Insulin Delivery (Dosing) Devices Price by Type (2027-2032) & (USD/unit) Table 16. North America Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 17. North America Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 19. Europe Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 23. Latin America Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (US$ Million) Table 26. Home Insulin Delivery (Dosing) Devices Industry Trends Table 27. Home Insulin Delivery (Dosing) Devices Industry Drivers Table 28. Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges Table 29. Home Insulin Delivery (Dosing) Devices Industry Restraints Table 30. Global Home Insulin Delivery (Dosing) Devices Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Company (2021-2026) Table 32. Global Home Insulin Delivery (Dosing) Devices Sales by Company (2021-2026) & (k units) Table 33. Global Home Insulin Delivery (Dosing) Devices Sales Share by Company (2021-2026) Table 34. Global Home Insulin Delivery (Dosing) Devices Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Home Insulin Delivery (Dosing) Devices Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Home Insulin Delivery (Dosing) Devices Major Company Production Sites and Headquarters Table 37. Global Home Insulin Delivery (Dosing) Devices Company, Product Type & Application Table 38. Global Home Insulin Delivery (Dosing) Devices Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Home Insulin Delivery (Dosing) Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Home Insulin Delivery (Dosing) Devices Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2026) & (k units) Table 43. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Region (2021-2026) Table 44. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2026) & (US$ Million) Table 45. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Region (2021-2026) Table 46. Global Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2027-2032) & (k units) Table 48. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Region (2027-2032) Table 49. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2027-2032) & (US$ Million) Table 50. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Region (2027-2032) Table 51. Global Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 54. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Application (2021-2026) Table 55. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (US$ Million) Table 56. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Application (2021-2026) Table 57. Global Home Insulin Delivery (Dosing) Devices Price by Application (2021-2026) & (USD/unit) Table 58. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (k units) Table 59. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Application (2027-2032) Table 60. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (US$ Million) Table 61. Global Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Application (2027-2032) Table 62. Global Home Insulin Delivery (Dosing) Devices Price by Application (2027-2032) & (USD/unit) Table 63. North America Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 64. North America Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 66. Europe Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 70. Latin America Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (US$ Million) Table 73. Medtronic Company Information Table 74. Medtronic Business Overview Table 75. Medtronic Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio Table 77. Medtronic Recent Development Table 78. Ypsomed Holding Company Information Table 79. Ypsomed Holding Business Overview Table 80. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio Table 82. Ypsomed Holding Recent Development Table 83. Wockhardt Company Information Table 84. Wockhardt Business Overview Table 85. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio Table 87. Wockhardt Recent Development Table 88. West Pharma Company Information Table 89. West Pharma Business Overview Table 90. West Pharma Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio Table 92. West Pharma Recent Development Table 93. Valeritas Company Information Table 94. Valeritas Business Overview Table 95. Valeritas Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio Table 97. Valeritas Recent Development Table 98. Tandem Diabetes Care Company Information Table 99. Tandem Diabetes Care Business Overview Table 100. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio Table 102. Tandem Diabetes Care Recent Development Table 103. SOOIL Company Information Table 104. SOOIL Business Overview Table 105. SOOIL Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio Table 107. SOOIL Recent Development Table 108. Sanofi Company Information Table 109. Sanofi Business Overview Table 110. Sanofi Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio Table 112. Sanofi Recent Development Table 113. Roche Holding AG Company Information Table 114. Roche Holding AG Business Overview Table 115. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio Table 117. Roche Holding AG Recent Development Table 118. Owen Mumford Company Information Table 119. Owen Mumford Business Overview Table 120. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio Table 122. Owen Mumford Recent Development Table 123. Novo Nordisk Company Information Table 124. Novo Nordisk Business Overview Table 125. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio Table 127. Novo Nordisk Recent Development Table 128. MannKind Company Information Table 129. MannKind Business Overview Table 130. MannKind Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio Table 132. MannKind Recent Development Table 133. Julphar Company Information Table 134. Julphar Business Overview Table 135. Julphar Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio Table 137. Julphar Recent Development Table 138. Insulet Corporation Company Information Table 139. Insulet Corporation Business Overview Table 140. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio Table 142. Insulet Corporation Recent Development Table 143. Eli Lilly and Company Company Information Table 144. Eli Lilly and Company Business Overview Table 145. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio Table 147. Eli Lilly and Company Recent Development Table 148. Debiotech Company Information Table 149. Debiotech Business Overview Table 150. Debiotech Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio Table 152. Debiotech Recent Development Table 153. Dance Biopharm Company Information Table 154. Dance Biopharm Business Overview Table 155. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio Table 157. Dance Biopharm Recent Development Table 158. Copernicus Company Information Table 159. Copernicus Business Overview Table 160. Copernicus Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio Table 162. Copernicus Recent Development Table 163. Biocon Company Information Table 164. Biocon Business Overview Table 165. Biocon Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio Table 167. Biocon Recent Development Table 168. Beta Bionics Company Information Table 169. Beta Bionics Business Overview Table 170. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio Table 172. Beta Bionics Recent Development Table 173. BD Company Information Table 174. BD Business Overview Table 175. BD Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 176. BD Home Insulin Delivery (Dosing) Devices Product Portfolio Table 177. BD Recent Development Table 178. B. Braun Company Information Table 179. B. Braun Business Overview Table 180. B. Braun Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 181. B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio Table 182. B. Braun Recent Development Table 183. North America Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 184. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 185. North America Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2026) Table 186. North America Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032) & (k units) Table 187. North America Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Country (2027-2032) Table 188. North America Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. North America Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026) & (US$ Million) Table 190. North America Home Insulin Delivery (Dosing) Devices Market Share by Country (2021-2026) Table 191. North America Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. North America Home Insulin Delivery (Dosing) Devices Market Share Forecast by Country (2027-2032) Table 193. Europe Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 194. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 195. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2026) Table 196. Europe Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032) & (k units) Table 197. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Country (2027-2032) Table 198. Europe Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Europe Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026) & (US$ Million) Table 200. Europe Home Insulin Delivery (Dosing) Devices Market Share by Country (2021-2026) Table 201. Europe Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Europe Home Insulin Delivery (Dosing) Devices Market Share Forecast by Country (2027-2032) Table 203. Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 204. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 205. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2026) Table 206. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032) & (k units) Table 207. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Country (2027-2032) Table 208. Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026) & (US$ Million) Table 210. Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Share by Country (2021-2026) Table 211. Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Share Forecast by Country (2027-2032) Table 213. Latin America Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 214. Latin America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 215. Latin America Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2026) Table 216. Latin America Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032) & (k units) Table 217. Latin America Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Country (2027-2032) Table 218. Latin America Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 219. Latin America Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026) & (US$ Million) Table 220. Latin America Home Insulin Delivery (Dosing) Devices Market Share by Country (2021-2026) Table 221. Latin America Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 222. Latin America Home Insulin Delivery (Dosing) Devices Market Share Forecast by Country (2027-2032) Table 223. Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 224. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 225. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2026) Table 226. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032) & (k units) Table 227. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Country (2027-2032) Table 228. Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 229. Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026) & (US$ Million) Table 230. Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Share by Country (2021-2026) Table 231. Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 232. Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Share Forecast by Country (2027-2032) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Home Insulin Delivery (Dosing) Devices Distributors List Table 236. Home Insulin Delivery (Dosing) Devices Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Home Insulin Delivery (Dosing) Devices Image Figure 2. Global Home Insulin Delivery (Dosing) Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Home Insulin Delivery (Dosing) Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Home Insulin Delivery (Dosing) Devices Sales (2021-2032) & (k units) Figure 5. Insulin Pumps Image Figure 6. Global Insulin Pumps Sales YoY Growth (2021-2032) & (k units) Figure 7. Insulin Pens Image Figure 8. Global Insulin Pens Sales YoY Growth (2021-2032) & (k units) Figure 9. Insulin Syringes Image Figure 10. Global Insulin Syringes Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Home Insulin Delivery (Dosing) Devices Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Home Insulin Delivery (Dosing) Devices Market Share by Type 2025 VS 2032 Figure 15. North America Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Type in 2025 Figure 16. North America Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Type in 2025 Figure 17. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Type in 2025 Figure 18. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Type in 2025 Figure 21. Latin America Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Home Insulin Delivery (Dosing) Devices Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Online Pharmacy Image Figure 28. Global Online Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospitals Pharmacy Image Figure 32. Global Hospitals Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Home Insulin Delivery (Dosing) Devices Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Home Insulin Delivery (Dosing) Devices Market Share by Application 2025 VS 2032 Figure 35. North America Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Application in 2025 Figure 36. North America Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Application in 2025 Figure 37. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Application in 2025 Figure 38. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Application in 2025 Figure 41. Latin America Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share in Value by Application in 2025 Figure 45. North America Home Insulin Delivery (Dosing) Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Home Insulin Delivery (Dosing) Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Home Insulin Delivery (Dosing) Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Home Insulin Delivery (Dosing) Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Home Insulin Delivery (Dosing) Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Home Insulin Delivery (Dosing) Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Home Insulin Delivery (Dosing) Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Home Insulin Delivery (Dosing) Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Home Insulin Delivery (Dosing) Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Home Insulin Delivery (Dosing) Devices Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Home Insulin Delivery (Dosing) Devices Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Others
Applications
  • Online Pharmacy
  • Retail Pharmacy
  • Hospitals Pharmacy
Companies covered
  • Medtronic
  • Ypsomed Holding
  • Wockhardt
  • West Pharma
  • Valeritas
  • Tandem Diabetes Care
  • SOOIL
  • Sanofi
  • Roche Holding AG
  • Owen Mumford
  • Novo Nordisk
  • MannKind
  • Julphar
  • Insulet Corporation
  • Eli Lilly and Company
  • Debiotech
  • Dance Biopharm
  • Copernicus
  • Biocon
  • Beta Bionics
  • BD
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Home Insulin Delivery (Dosing) Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Home Insulin Delivery (Dosing) Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Home Insulin Delivery (Dosing) Devices Market by Type
  6. 1.3.1 Insulin Pumps
  7. 1.3.2 Insulin Pens
  8. 1.3.3 Insulin Syringes
  9. 1.3.4 Others
  10. 1.4 Global Home Insulin Delivery (Dosing) Devices Market Size by Type
  11. 1.4.1 Global Home Insulin Delivery (Dosing) Devices Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Home Insulin Delivery (Dosing) Devices Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Home Insulin Delivery (Dosing) Devices Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Home Insulin Delivery (Dosing) Devices Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Home Insulin Delivery (Dosing) Devices Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Home Insulin Delivery (Dosing) Devices Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Home Insulin Delivery (Dosing) Devices Industry Trends
  2. 2.2 Home Insulin Delivery (Dosing) Devices Industry Drivers
  3. 2.3 Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges
  4. 2.4 Home Insulin Delivery (Dosing) Devices Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Home Insulin Delivery (Dosing) Devices Revenue (2021-2026)
  2. 3.2 Global Top Players by Home Insulin Delivery (Dosing) Devices Sales (2021-2026)
  3. 3.3 Global Top Players by Home Insulin Delivery (Dosing) Devices Price (2021-2026)
  4. 3.4 Global Home Insulin Delivery (Dosing) Devices Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Home Insulin Delivery (Dosing) Devices Major Company Production Sites & Headquarters
  6. 3.6 Global Home Insulin Delivery (Dosing) Devices Company, Product Type & Application
  7. 3.7 Global Home Insulin Delivery (Dosing) Devices Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Home Insulin Delivery (Dosing) Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Home Insulin Delivery (Dosing) Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Home Insulin Delivery (Dosing) Devices Tier 1, Tier 2, and Tier 3
4 Home Insulin Delivery (Dosing) Devices Regional Status and Outlook
  1. 4.1 Global Home Insulin Delivery (Dosing) Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Home Insulin Delivery (Dosing) Devices Historic Market Size by Region
  3. 4.2.1 Global Home Insulin Delivery (Dosing) Devices Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Home Insulin Delivery (Dosing) Devices Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Home Insulin Delivery (Dosing) Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Home Insulin Delivery (Dosing) Devices Forecasted Market Size by Region
  7. 4.3.1 Global Home Insulin Delivery (Dosing) Devices Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Home Insulin Delivery (Dosing) Devices Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Home Insulin Delivery (Dosing) Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Home Insulin Delivery (Dosing) Devices by Application
  1. 5.1 Home Insulin Delivery (Dosing) Devices Market by Application
  2. 5.1.1 Online Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Hospitals Pharmacy
  5. 5.2 Global Home Insulin Delivery (Dosing) Devices Market Size by Application
  6. 5.2.1 Global Home Insulin Delivery (Dosing) Devices Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Home Insulin Delivery (Dosing) Devices Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Home Insulin Delivery (Dosing) Devices Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Home Insulin Delivery (Dosing) Devices Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Home Insulin Delivery (Dosing) Devices Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Home Insulin Delivery (Dosing) Devices Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Medtronic
  2. 6.1.1 Medtronic Company Information
  3. 6.1.2 Medtronic Business Overview
  4. 6.1.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio
  6. 6.1.5 Medtronic Recent Developments
  7. 6.2 Ypsomed Holding
  8. 6.2.1 Ypsomed Holding Company Information
  9. 6.2.2 Ypsomed Holding Business Overview
  10. 6.2.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio
  12. 6.2.5 Ypsomed Holding Recent Developments
  13. 6.3 Wockhardt
  14. 6.3.1 Wockhardt Company Information
  15. 6.3.2 Wockhardt Business Overview
  16. 6.3.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio
  18. 6.3.5 Wockhardt Recent Developments
  19. 6.4 West Pharma
  20. 6.4.1 West Pharma Company Information
  21. 6.4.2 West Pharma Business Overview
  22. 6.4.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio
  24. 6.4.5 West Pharma Recent Developments
  25. 6.5 Valeritas
  26. 6.5.1 Valeritas Company Information
  27. 6.5.2 Valeritas Business Overview
  28. 6.5.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio
  30. 6.5.5 Valeritas Recent Developments
  31. 6.6 Tandem Diabetes Care
  32. 6.6.1 Tandem Diabetes Care Company Information
  33. 6.6.2 Tandem Diabetes Care Business Overview
  34. 6.6.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio
  36. 6.6.5 Tandem Diabetes Care Recent Developments
  37. 6.7 SOOIL
  38. 6.7.1 SOOIL Company Information
  39. 6.7.2 SOOIL Business Overview
  40. 6.7.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio
  42. 6.7.5 SOOIL Recent Developments
  43. 6.8 Sanofi
  44. 6.8.1 Sanofi Company Information
  45. 6.8.2 Sanofi Business Overview
  46. 6.8.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio
  48. 6.8.5 Sanofi Recent Developments
  49. 6.9 Roche Holding AG
  50. 6.9.1 Roche Holding AG Company Information
  51. 6.9.2 Roche Holding AG Business Overview
  52. 6.9.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio
  54. 6.9.5 Roche Holding AG Recent Developments
  55. 6.10 Owen Mumford
  56. 6.10.1 Owen Mumford Company Information
  57. 6.10.2 Owen Mumford Business Overview
  58. 6.10.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio
  60. 6.10.5 Owen Mumford Recent Developments
  61. 6.11 Novo Nordisk
  62. 6.11.1 Novo Nordisk Company Information
  63. 6.11.2 Novo Nordisk Business Overview
  64. 6.11.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio
  66. 6.11.5 Novo Nordisk Recent Developments
  67. 6.12 MannKind
  68. 6.12.1 MannKind Company Information
  69. 6.12.2 MannKind Business Overview
  70. 6.12.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio
  72. 6.12.5 MannKind Recent Developments
  73. 6.13 Julphar
  74. 6.13.1 Julphar Company Information
  75. 6.13.2 Julphar Business Overview
  76. 6.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio
  78. 6.13.5 Julphar Recent Developments
  79. 6.14 Insulet Corporation
  80. 6.14.1 Insulet Corporation Company Information
  81. 6.14.2 Insulet Corporation Business Overview
  82. 6.14.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio
  84. 6.14.5 Insulet Corporation Recent Developments
  85. 6.15 Eli Lilly and Company
  86. 6.15.1 Eli Lilly and Company Company Information
  87. 6.15.2 Eli Lilly and Company Business Overview
  88. 6.15.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio
  90. 6.15.5 Eli Lilly and Company Recent Developments
  91. 6.16 Debiotech
  92. 6.16.1 Debiotech Company Information
  93. 6.16.2 Debiotech Business Overview
  94. 6.16.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio
  96. 6.16.5 Debiotech Recent Developments
  97. 6.17 Dance Biopharm
  98. 6.17.1 Dance Biopharm Company Information
  99. 6.17.2 Dance Biopharm Business Overview
  100. 6.17.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio
  102. 6.17.5 Dance Biopharm Recent Developments
  103. 6.18 Copernicus
  104. 6.18.1 Copernicus Company Information
  105. 6.18.2 Copernicus Business Overview
  106. 6.18.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio
  108. 6.18.5 Copernicus Recent Developments
  109. 6.19 Biocon
  110. 6.19.1 Biocon Company Information
  111. 6.19.2 Biocon Business Overview
  112. 6.19.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio
  114. 6.19.5 Biocon Recent Developments
  115. 6.20 Beta Bionics
  116. 6.20.1 Beta Bionics Company Information
  117. 6.20.2 Beta Bionics Business Overview
  118. 6.20.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio
  120. 6.20.5 Beta Bionics Recent Developments
  121. 6.21 BD
  122. 6.21.1 BD Company Information
  123. 6.21.2 BD Business Overview
  124. 6.21.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 BD Home Insulin Delivery (Dosing) Devices Product Portfolio
  126. 6.21.5 BD Recent Developments
  127. 6.22 B. Braun
  128. 6.22.1 B. Braun Company Information
  129. 6.22.2 B. Braun Business Overview
  130. 6.22.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio
  132. 6.22.5 B. Braun Recent Developments
7 North America by Country
  1. 7.1 North America Home Insulin Delivery (Dosing) Devices Sales by Country
  2. 7.1.1 North America Home Insulin Delivery (Dosing) Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026)
  4. 7.1.3 North America Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032)
  5. 7.2 North America Home Insulin Delivery (Dosing) Devices Market Size by Country
  6. 7.2.1 North America Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026)
  8. 7.2.3 North America Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country
  2. 8.1.1 Europe Home Insulin Delivery (Dosing) Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026)
  4. 8.1.3 Europe Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Home Insulin Delivery (Dosing) Devices Market Size by Country
  6. 8.2.1 Europe Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026)
  8. 8.2.3 Europe Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales by Country
  2. 9.1.1 Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Size by Country
  6. 9.2.1 Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Home Insulin Delivery (Dosing) Devices Sales by Country
  2. 10.1.1 South America Home Insulin Delivery (Dosing) Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026)
  4. 10.1.3 South America Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032)
  5. 10.2 South America Home Insulin Delivery (Dosing) Devices Market Size by Country
  6. 10.2.1 South America Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026)
  8. 10.2.3 South America Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country
  2. 11.1.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size by Country
  6. 11.2.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Home Insulin Delivery (Dosing) Devices Value Chain Analysis
  2. 12.1.1 Home Insulin Delivery (Dosing) Devices Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Home Insulin Delivery (Dosing) Devices Production Mode & Process
  7. 12.2 Home Insulin Delivery (Dosing) Devices Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Home Insulin Delivery (Dosing) Devices Distributors
  10. 12.2.3 Home Insulin Delivery (Dosing) Devices Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst